Dilair Camargo de Souza

Dilair Camargo de Souza

Auto-generated profile, based on publicly available information

Dilair Camargo de Souza

Univ Fed Parana, Complexo Hosp Clin, Lab Bacteriol, Curitiba, Parana, Brazil

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2020 in Pediatric Pulmonology
Verified
Journal Article
Closed access
PDF file
DSDilair C. de Souza
Dilair C. de Souza
LCLaura L. Cogo
Laura L. Cogo
JPJussara K. Palmeiro
Jussara K. Palmeiro
LDLibera M. Dalla‐Costa
Libera M. Dalla‐Costa
ATAna P. de Oliveira Tomaz
Ana P. de Oliveira Tomaz
NRNelson Rosario
Nelson Rosario

3 September 2021 in Microbiology Spectrum
Verified
Journal Article
Open access
DSDilair Camargo de Souza
Dilair Camargo de Souza
LCLaura Lucia Cogo
Laura Lucia Cogo
LDLIBERA MARIA DALLA-COSTA
LIBERA MARIA DALLA-COSTA
ATAna Paula Oliveira Tomaz
Ana Paula Oliveira Tomaz
DCDanieli Conte
Danieli Conte
JPJussara Kasuko Palmeiro
Jussara Kasuko Palmeiro
Similar findings have not yet been reported in Brazil, emphasizing the importance of monitoring small-colony variants (SCVs). Altogether, our results highlight the need to improve detection methods and review antimicrobial therapy protocols in cystic fibrosis (CF) patients.

18 September 2024 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
ATAna Paula Oliveira Tomaz
Ana Paula Oliveira Tomaz
DSDilair Camargo de Souza
Dilair Camargo de Souza
LCLaura Lucia Cogo
Laura Lucia Cogo
JPJussara Kasuko Palmeiro
Jussara Kasuko Palmeiro
KNKEITE da Silva NOGUEIRA
KEITE da Silva NOGUEIRA
LDLIBERA MARIA DALLA-COSTA
LIBERA MARIA DALLA-COSTA
Objective: Thymidine-dependent small-colony variants (TD-SCVs) of Staphylococcus aureus are being isolated with increasing frequency from patients with cystic fibrosis (CF). The aim of this study was to evaluate the relationship between TD-SCV isolation and pulmonary function in patients with CF, as well as to determine whether the emergence of TD-SCVs was associated with trimethoprim-sulfamethoxazole (TMP-SMX) use and with coinfection with other microorganisms. Methods: This was a retrospective case-control study including patients with CF who visited the Clinical Hospital Complex of the Federal University of Paraná, in Curitiba, Brazil, between 2013 and 2022. Demographic, clinical, and spirometric data, as well as information on TD-SCVs and other isolated microorganisms, were collected from the medical records of patients with CF and TD-SCVs (TD-SCV group; n = 32) and compared with those of a matched group of patients with CF without TD-SCVs (control group; n = 64). Results: Isolation of TD-SCVs was positively associated with TMP-SMX use (p = 0.009), hospitalization (p < 0.001), and impaired pulmonary function (p = 0.04). Conclusions: The use of TMP-SMX seems to contribute to the emergence of TD-SCVs, the isolation of which was directly associated with worse pulmonary function in our sample.